Reply to Dr. Roggenbuck et al.'s letter

Journal of Crohn's and Colitis

Volumn 7, Issue 7, 2013, Pages

  Stöcker, Winfried ^a   Probst, Christian ^a   Komorowski, Lars ^a  

^a Institute of Experimental Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL STRAIN HEK293; CROHN DISEASE; CROSS REACTION; CULTURE MEDIUM; DELETION MUTANT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; LETTER; PANCREAS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS;

AUTOANTIBODIES; COLITIS, ULCERATIVE; CROHN DISEASE; GPI-LINKED PROTEINS; HUMANS; IMMUNE TOLERANCE; MEMBRANE PROTEINS;

EID: 84878642518     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.02.003     Document Type: Letter

References (5)

1. Komorowski L., Teegen B., Probst C., Aulinger-Stöcker K., Sina C., Fellermann K., et al. Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2. J Crohns Colitis Nov 6 2012.
2. Roggenbuck D., Reinhold D., Wex T., Goihl A., von A.U., Malfertheiner P., et al. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease. Clin Chim Acta Dec 30 2010, 412(9-10):718-724.
3. Harrison R.L., Jarvis D.L. Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce "mammalianized" recombinant glycoproteins. Adv Virus Res 2006, 68:159-191.
4. Teegen B., Müller-Kunert E., Zerbe B., Dähnrich C., Groeury M., Humbel R.L., et al. Prevalence of antibodies against Saccharomyces cerevisiae in the diagnosis of chronic-inflammatory bowel disease. J Lab Med 2000, 24:494.
5. Op De Beeck K., Vermeire S., Rutgeerts P., Bossuyt X. Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases. Gut 2012, 61:162-164.